Self-directed versus therapist-directed cognitive behavioral treatment for panic disorder

Hecker, Jeffrey E.; Losee, Melinda C.; Fritzler, Bryan K.; Fink, Christine M.

doi:10.1016/0887-6185(96)00010-2

Cited by 60 publications

(41 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The SAT for phobias was self-administered desensitization (Ghosh & Marks, 1987;Hellström & Ö st, 1995;Ö st, Salkovskis, & Hellström, 1991;Rosen, Glasgow, & Barrera, 1976). With the exception of Carlbring, Westling, Ljungstrand, Ekselius, and Anderson (2001), who evaluated the efficacy of an Internet-based cognitive-behavioral treatment, panic studies used bibliotherapy, either alone (Febbraro, Clum, Roodman, & Wright, 1999;Gould, Clum, & Shapiro, 1993;Hecker, Losee, Fritzler, & Fink, 1996;Lidren et al, 1994) or with other interventions such as monitoring (Febbraro et al, 1999) or video-and/or audiotapes (Gould & Clum, 1995;Parry & Killick, 1998;White, 1995).…”

Section: Description Of the Studiesmentioning

confidence: 99%

Efficacy of self-administered treatments for depression and anxiety.

Menchola

Arkowitz

Burke

2007

Professional Psychology: Research and Practice

View full text Add to dashboard Cite

Self-administered treatments (SATs) are widely used by the general public and mental health professionals. Previous reviews of the efficacy of SATs have included under this category interventions for nonclinical problems, group interventions, and interventions involving significant amounts of therapist contact. The efficacy of SATs for clinical levels of depression and anxiety with minimal therapeutic contact was examined by meta-analyzing 24 studies. The results show large effects for SATs when compared with no-treatment control groups (d ϭ 1.00). However, unlike previous meta-analyses that found nonsignificant differences between SATs and therapist-administered treatments, in this sample SATs resulted in significantly poorer outcomes (d ϭ -0.31). Some differences in effect size were observed between the clinical targets of depression and anxiety. However, there were high correlations between clinical target, methodological quality of the study, and amount of contact. This makes it impossible to determine whether the observed differences could be explained by the nature of the disorders, methodological quality, or the amount of contact with a member of the research team. The implications of the findings for the clinical use of SATs and for future research are discussed.

show abstract

Section: Description Of the Studiesmentioning

confidence: 99%

Efficacy of self-administered treatments for depression and anxiety.

Menchola

Arkowitz

Burke

2007

Professional Psychology: Research and Practice

View full text Add to dashboard Cite

show abstract

“…The principal drawbacks of cognitive behavior therapy relative to pharmacotherapy are its limited availability outside specialty clinics, the time required to administer it (typically 10-15 sessions, although shorter versions and self-administered forms are being studied [52][53][54][55]), and the need for patients' active participation in treatment, including engagement in anxiety-provoking exercises and homework assignments. Many patients refuse cognitive behavior therapy or drop out of it.…”

Section: Cognitive Behavior Therapymentioning

confidence: 99%

Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials

Spiegel

Bruce²

1997

AJP

View full text Add to dashboard Cite

“…El alprazolam no perturbó la eficacia del programa cognitivo-comportamental, y si tuvo algún efecto en el mismo éste fue beneficioso para los pacientes. Estos datos van en contra de la idea de Barlow (1988) y de los resultados de Marks et al (1993) que señalan que el uso de medicación, en concreto benzodiacepinas, puede interferir negativamente en los resultados de la terapia cognitivo-comportamental, y apoyan los resultados de Cóté et al (1994), Hecker et al (1996) y Oei eí al. (1997 que tampoco encuentran diferencias.…”

Section: Discussionunclassified

“…Es decir, no se trata de un tratamiento que desde el principio se haya pautado combinando fármacos y terapia cognitivocomportamental, sino de la aplicación de un programa psicológico a pacientes que podían o no estar tomando medicación. Lo mismo ocurre en los estudios de Cóté et al, (1994), Hecker et al (1996) y Oei et al, (1997). Existen otros estudios que sí estudian la influencia de benzodiacepinas, por ejemplo el de Marks et al (1993), que encontró que el alprazolam sí interfería en el mantenimiento de los logros conseguidos con exposición.…”

Section: Discussionunclassified

“…Existen algunos trabajos que tenían como objetivo el estudio de la eficacia de programas cognitivo-comportamentales para el trastorno de pánico, al encontrar que una parte de la muestra tomaba ya fármacos al iniciar el programa cognitivocomportamental, analizaron si este uso concurrente de medicación tenía alguna influencia en la eficacia del tratamiento psicológico (Cote Gauthier, Laberge, Cormier y Plamondon, 1994;Hecker, Losee, Fritzler y Fink, 1996;Oei, Llamas y Evans, 1997).…”

Section: Introductionunclassified

See 1 more Smart Citation

La interferencia de la utilización concurrente de Alprazolam en el tratamiento cognitivo-comportamental del trastorno de pánico

Palacios¹,

Arbona²

1998

RPPC

View full text Add to dashboard Cite

El presente estudio analiza el papel de la utilización concurrente del alprazolam en la eficacia de la terapia cognitivo-comportamental para el trastorno de pánico. El trabajo se engloba dentro de un estudio previo más amplio. El objetivo de dicho estudio fue estudiar la eficacia diferencial de dos tratamientos, uno estándar y otro abreviado apoyado por manuales de autoayuda. Los resultados indicaron que ambos tratamientos eran igualmente eficaces. El objetivo del presente estudio es analizar la eficacia diferencial en función de si los pacientes tomaban o no alprazolam. Los resultados indican que, en prácticamente la totalidad de las variables analizadas, los sujetos mejoran por igual en el postest y en el seguimiento (a los doce meses de finalizada la terapia), independientemente de si empezaron el programa cognitivo-comportamental tomando o no un tratamiento farmacológico (alprazolam).Palabras clave: Trastorno de pánico, terapia cognitivo-comportamental, alprazolam. Interference ofthe use of alprazolam in the cognitive-behavioral treatment for panicdisorder This study analyzes the role of alprazolam in the therapeutic effectiveness of cognitive-behavioral treatments for panic disorder. This work belongs to a wider study virhich aim was to study the differential effectiveness of two programs, a standard one and a brief one supported by self-help manuals. We demonstrated the effectiveness of both interventions. The aim of the present study is to analyzed the differential effectiveness according to the use of alprazolam. The results shows that the patients who used alprazolam improve as well as patients that didn't use it in mostly of the analyzed variables at postest and foUow-up assessment

show abstract

Self-directed versus therapist-directed cognitive behavioral treatment for panic disorder

Cited by 60 publications

References 13 publications

Efficacy of self-administered treatments for depression and anxiety.

Efficacy of self-administered treatments for depression and anxiety.

Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials

La interferencia de la utilización concurrente de Alprazolam en el tratamiento cognitivo-comportamental del trastorno de pánico

Contact Info

Product

Resources

About